The pathogenesis of atherosclerosis

Clinica Chimica Acta

Volumn 246, Issue 1-2, 1996, Pages 21-38

  Hegele, Robert A ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b ST MICHAEL'S HOSPITAL   (Canada)

Author keywords

Atherosclerosis; Genetics; Multifactorial disease; Pathology; Thrombosis

Indexed keywords

AGED; ATHEROSCLEROSIS; CONFERENCE PAPER; CYTOCHEMISTRY; DIABETES MELLITUS; FEMALE; GENETIC ANALYSIS; HEREDITY; HISTOCHEMISTRY; HUMAN; HYPERTENSION; LIPID METABOLISM; MALE; PRIORITY JOURNAL; RISK FACTOR; SEX DIFFERENCE; SMOKING;

EID: 0029963147     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/0009-8981(96)06224-9     Document Type: Conference Paper

References (19)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1993;362:801-809.
2. DeBakey ME. Patterns of atherosclerosis and rates of progression. Atherosclerosis 1978;3:1-56.
3. Gown AM, Tsukada T, Ross R. Human atherosclerosis. II. Immunocytochemical analysis of the cellular composition of human atherosclerotic lesions. Am J Pathol 1986;125:191-207.
4. Feldman DL, Hoff H, Gerrity RG. Immunohistochemical localization of apoprotein B in aortas from hyperlipemic swine: preferential accumulation in lesion-prone areas. Arch Pathol Lab Med 1984;108:817-822.
5. Gerrity RG. The role of the monocyte in atherogenesis. I. Transition of blood-borne monocytes into foam cells in fatty lesions. Am J Pathol 1981;103:181-190.
6. Steinberg D, Parasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol: modifications of low-density lipoproteins that increase its atherogenicity. N Engl J Med 1989;320:915-924.
7. Stary HC. Changes in the cells of atherosclerotic lesions as advanced lesions evolve in coronary arteries of children and young adults. In: Glagov S, Newman WP, Schaffer SA, eds. Pathobiology of the human atherosclerotic plaque. New York: Springer, 1990;93-106.
8. Bocan TMA, Schifani TA, Guyton JR. Ultrastructure of the human aortic fibrolipid lesion: formation of the atherosclerotic lipid-rich core. Am J Pathol 1986;123:413-424.
9. Constantinides P. Plaque ruptures, their genesis and their role in supraplaque thrombosis and atherogenesis. In: Glagov S, Newman WP, Schaffer SA, eds. Pathobiology of the human atherosclerotic plaque. New York: Springer, 1990:393-411.
10. Hawiger J. Adhesive interactions of the blood cells and the vascular wall. In: Colman RW, Hirsch J, Marder VJ, eds. Hemostasis and thrombosis: basic principles and clinical practice. Philadelphia: JB Lippincott, 1994:762-796.
11. Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994;120:1026-1036.
12. Marenberg ME, Risch N, Berman LF, Floderus B, deFaire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994;330:1041-1046.
13. Davignon J, Roy M. Familial hypercholesterolemia in French Canadians: taking advantage of a "founder effect". Am J Cardiol 1993;72:6D-10D.
14. Mehrabian M, Lusis AJ. Genetic markers for studies of atherosclerosis and related risk factors. In: Lusis AJ, Rotter JI, Sparkes RS, eds. Molecular genetics of coronary artery disease: candidate genes and processes in atherosclerosis. Monograph in Human Genetics. Basel: Karger, 1992:363-418.
15. Sing CF, Haviland MB, Templeton AR, Reilly SL. Alternative genetic strategies for predicting risk of atherosclerosis. Atherosclerosis 1994;109:333.
16. Brown GB, Zhao X-Q, Sacco D, Albers JJ. Lipid lowering plaque regression. Circulation 1993;87:1781-1791.
17. Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study. Lancet 1994;344:1383-1389.
18. Hegele RA, Emi M, Wu LL, Hopkins PN, Williams RR, Lalouel JM. Clinical application of deoxyribonucleic acid markers in a Utah family with hypercholesterolemia. Am J Cardiol 1989;63:109-112.
19. Hegele RA. Gene-environment interactions in atherosclerosis. Mol Cell Biochem 1992;113:177-188.